Sulodexide and glycosaminoglycans in the progression of renal disease - Wikidata - awgldk - TriplyDB

Sulodexide and glycosaminoglycans in the progression of renal disease

Sulodexide and glycosaminoglycans in the progression of renal disease

http://www.wikidata.org/entity/Q26991825

about

Impact of heparanase on renal fibrosis Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review Diabetic nephropathy - complications and treatment.Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats.Endothelial glycocalyx-the battleground for complications of sepsis and kidney injury.Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells.A glimpse of diabetic nephropathy.

P2860

Q28083753-5B487435-AA9C-4DC2-8331-F055B5E41A76 Q28083781-421901FA-E718-4E0D-A3E1-3754ADD9F682 Q34387952-35F523B2-DD55-4152-BB97-7081594B8E2E Q37706096-4322681C-9EB7-44DC-8228-1073D7FD31D6 Q38768931-F72F072B-2A12-4EEB-A697-CA26DEC2D074 Q38866153-A761873C-83E9-441D-A73F-135D2C942627 Q53692354-B88FF520-6A17-4101-B291-F07601FB8E37

P2860

Sulodexide and glycosaminoglycans in the progression of renal disease

http://www.wikidata.org/entity/Q26991825

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sulodexide and glycosaminoglycans in the progression of renal disease

@ast

Sulodexide and glycosaminoglycans in the progression of renal disease

@en

Sulodexide and glycosaminoglycans in the progression of renal disease

@nl

type

label

Sulodexide and glycosaminoglycans in the progression of renal disease

@ast

Sulodexide and glycosaminoglycans in the progression of renal disease

@en

Sulodexide and glycosaminoglycans in the progression of renal disease

@nl

prefLabel

Sulodexide and glycosaminoglycans in the progression of renal disease

@ast

Sulodexide and glycosaminoglycans in the progression of renal disease

@en

Sulodexide and glycosaminoglycans in the progression of renal disease

@nl

P1433

Q26991825-1061A913-6FD4-4F4E-BADE-496FADCC3F76

P1476

Q26991825-C7950CDD-4B29-431A-AEA7-74547A898E89

P2093

Q26991825-AE65762A-BE1F-49F0-AE19-80B81AD29462

P2860

Q26991825-2344AD92-7B9F-48AC-AFDF-44C64F9BFA00

Q26991825-29DC520C-6ED3-43FD-ABC8-3A8D4DCB958F

Q26991825-31C1456B-82EC-4359-973A-1E2A20876135

Q26991825-36662021-E6BE-412B-AD93-B16A3213456D

Q26991825-46E35F9E-21A2-4A8C-A88D-714EBCA353D7

Q26991825-4B9144FE-5A76-44AF-AB62-BD6124615D54

Q26991825-4BA2462C-5845-4988-A38D-4ABECA902218

Q26991825-4BCB53A6-6ED6-4C3A-B43A-EF53F777F6E1

Q26991825-687A705F-7039-4BC7-835B-7F7544F69402

Q26991825-6FBB1F7E-6764-474F-BCDE-032019225FE3

P304

Q26991825-F60DEFA3-0D69-47CE-9510-AAB4607560AA

P31

Q26991825-B3D8EF64-F6D0-40A9-B575-90056D38020A

P356

Q26991825-3D1B624F-479E-4DFE-9E00-64A782BF89DA

P407

Q26991825-9A2D5A45-176C-4FF6-9415-D6920582D7C8

P478

Q26991825-4A23A196-F8EE-41A0-983B-8B72C8A266CD

P50

Q26991825-33CC9E43-55E4-4F1E-B0C8-294AFE873B8A

Q26991825-3BB16457-2B3F-4B51-AF3D-7A29AB7D3F75

P577

Q26991825-3B834C11-1528-4D72-B358-4A6901D58880

P698

Q26991825-02B96EDB-2318-49C4-8D80-6F0931BEE6B8

P356

P1433

Nephrology Dialysis Transplantation

P1476

Sulodexide and glycosaminoglycans in the progression of renal disease

@en

P2093

Giovanni Gambaro

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Heparanase in glomerular diseases

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.

Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy

Anti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.

N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.

Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.

P304

i74-i79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFT389

http://www.w3.org/2001/XMLSchema#string

P407

P478

29 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Masola

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24493873

http://www.w3.org/2001/XMLSchema#string